CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM, INC.;ALBANY COLLEGE OF PHARMACY
发明人:
DAVIS, PAUL J.,MOUSA, SHAKER A.
申请号：
CA2673133
公开号：
CA2673133C
申请日:
2007.12.21
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric Nanoparticle form of thyroid hormone antagonist to inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone antagonists, are also disclosed.
